- cafead Apr 29, 2022 at 11:02: AM
via Dexcom winning a nod from FDA for the G7 continuous glucose monitoring system is one of the biggest questions in Diabetes Tech.
During a 1Q22 earnings call, the San Diego, CA-based company’s President, CEO, and chairman, Kevin Sawyer, shed more light on when one of medtech’s most anticipated devices could obtain a nod from FDA.
article source
During a 1Q22 earnings call, the San Diego, CA-based company’s President, CEO, and chairman, Kevin Sawyer, shed more light on when one of medtech’s most anticipated devices could obtain a nod from FDA.
article source